Pascal Sirand-Pugnet

Dr. Pascal Sirand-Pugnet

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2022 in ACS Synthetic Biology
Verified
Journal Article
Open access
VTVincent Talenton
Vincent Talenton
VBVincent Baby
Vincent Baby
GGGeraldine Gourgues
Geraldine Gourgues
CMCharlotte Mouden
Charlotte Mouden
SCStephane Claverol
Stephane Claverol
CLCarole Lartigue
Carole Lartigue
Development of a new generation of vaccines is a key challenge for the control of infectious diseases affecting both humans and animals. Synthetic biology methods offer new ways to engineer bacterial chassis that can be used as vectors to present heterologous antigens and train the immune system against pathogens. Here, we describe the construction of a bacterial chassis based on the fast-growing Mycoplasma feriruminatoris, and the first steps toward its application as a live vaccine against contagious caprine pleuropneumonia (CCPP). To do so, the M. feriruminatoris genome was cloned in yeast, modified by iterative cycles of Cas9-mediated deletion of loci encoding virulence factors, and transplanted back in Mycoplasma capricolum subsp. capricolum recipient cells to produce the designed M. feriruminatoris chassis. Deleted genes encoded the glycerol transport and metabolism systems GtsABCD and GlpOKF and the Mycoplasma Ig binding protein-Mycoplasma Ig protease (MIB-MIP) immunoglobulin cleavage system. Phenotypic assays of the M. feriruminatoris chassis confirmed the corresponding loss of H2O2 production and IgG cleavage activities, while growth remained unaltered. The resulting mycoplasma chassis was further evaluated as a platform for the expression of heterologous surface proteins. A genome locus encoding an inactivated MIB-MIP system from the CCPP-causative agent Mycoplasma capricolum subsp. capripneumoniae was grafted in replacement of its homolog at the original locus in the chassis genome. Both heterologous proteins were detected in the resulting strain using proteomics, confirming their expression. This study demonstrates that advanced genome engineering methods are henceforth available for the fast-growing M. feriruminatoris, facilitating the development of novel vaccines, in particular against major mycoplasma diseases.

13 September 2022 in Applied and Environmental Microbiology
Verified
Journal Article
Open access
TIThomas Ipoutcha
Thomas Ipoutcha
FRFabien Rideau
Fabien Rideau
GGGeraldine Gourgues
Geraldine Gourgues
YAYonathan Arfi
Yonathan Arfi
CLCarole Lartigue
Carole Lartigue
PSPascal Sirand-Pugnet
Pascal Sirand-Pugnet
Mycoplasmas are minimal pathogenic bacteria that infect a wide range of hosts, including humans, livestock, and wild animals. Major pathogenic species cause acute to chronic infections involving still poorly characterized virulence factors.

15 November 2024 in Microbial Genomics
Verified
Journal Article
Open access
XYXiao-Hua Yan
Xiao-Hua Yan
SPShen-Chian Pei
Shen-Chian Pei
HYHsi-Ching Yen
Hsi-Ching Yen
ABAlain Blanchard
Alain Blanchard
PSPascal Sirand-Pugnet
Pascal Sirand-Pugnet
CKChih-Horng Kuo
Chih-Horng Kuo
Genome-based analysis allows for large-scale classification of diverse bacteria and has been widely adopted for delineating species. Unfortunately, for higher taxonomic ranks such as genus, establishing a generally accepted approach based on genome analysis is challenging. While core-genome phylogenies depict the evolutionary relationships among species, determining the correspondence between clades and genera may not be straightforward. For genotypic divergence, the percentage of conserved proteins and genome-wide average amino acid identity are commonly used, but often do not provide a clear threshold for classification. In this work, we investigated the utility of global comparisons and data visualization in identifying clusters of species based on their overall gene content and rationalized that such patterns can be integrated with phylogeny and other information such as phenotypes for improving taxonomy. As a proof of concept, we selected 177 representative genome sequences from the Mycoplasmatales–Entomoplasmatales clade within the class Mollicutes for a case study. We found that the clustering patterns corresponded to the current understanding of these organisms, namely the split into three above-genus groups: Hominis, Pneumoniae and Spiroplasma–Entomoplasmataceae–Mycoides. However, at the genus level, several important issues were found. For example, recent taxonomic revisions that split the Hominis group into three genera and Entomoplasmataceae into five genera are problematic, as those newly described or emended genera lack clear differentiations in gene content from one another. Moreover, several cases of misclassification were identified. These findings demonstrated the utility of this approach and its potential application to other bacteria.

15 February 2022 in ACS Synthetic Biology
Verified
Journal Article
Open access
TIThomas Ipoutcha
Thomas Ipoutcha
GGGéraldine Gourgues
Géraldine Gourgues
CLCarole Lartigue
Carole Lartigue
ABAlain Blanchard
Alain Blanchard
PSPascal Sirand-Pugnet
Pascal Sirand-Pugnet
Mycoplasma gallisepticum (Mgal) is a common pathogen of poultry worldwide that has recently spread to North American house finches after a single host shift in 1994. The molecular determinants of Mgal virulence and host specificity are still largely unknown, mostly due to the absence of efficient methods for functional genomics. After evaluating two exogenous recombination systems derived from phages found in the phylogenetically related Spiroplasma phoeniceum and the more distant Bacillus subtilis, the RecET-like system from B. subtilis was successfully used for gene inactivation and targeted replacement in Mgal. In a second step, the Cre-lox recombination system was used for the removal of the antibiotic resistance marker in recombinant mutants. This study therefore describes the first genetic tool for targeted genome engineering of Mgal and demonstrates the efficiency of heterologous recombination systems in minimal bacteria.

1 April 2007 in Research in Microbiology
Verified
Journal Article
Closed access
MUMarina Uhart
Marina Uhart
PSPascal Sirand-Pugnet
Pascal Sirand-Pugnet
JLJacques Labarère
Jacques Labarère

16 October 2023 in ACS Synthetic Biology
Verified
Journal Article
Open access
GGGabrielle Guesdon
Gabrielle Guesdon
GGGéraldine Gourgues
Géraldine Gourgues
FRFabien Rideau
Fabien Rideau
TIThomas Ipoutcha
Thomas Ipoutcha
LMLucía Manso-Silván
Lucía Manso-Silván
CLCarole Lartigue
Carole Lartigue
The genetic engineering of genome fragments larger than 100 kbp is challenging and requires both specific methods and cloning hosts. The yeast Saccharomyces cerevisiae is considered as a host of choice for cloning and engineering whole or partial genomes from viruses, bacteria, and algae. Several methods are now available to perform these manipulations, each with its own limitations. In order to extend the range of yeast cloning strategies, a new approach combining two already described methods, Fusion cloning and CReasPy-Cloning, was developed. The CReasPy-Fusion method allows the simultaneous cloning and engineering of megabase-sized genomes in yeast by the fusion of bacterial cells with yeast spheroplasts carrying the CRISPR-Cas9 system. With this new approach, we demonstrate the feasibility of cloning and editing whole genomes from several Mycoplasma species belonging to different phylogenetic groups. We also show that CReasPy-Fusion allows the capture of large genome fragments with high efficacy, resulting in the successful cloning of selected loci in yeast. We finally identify bacterial nuclease encoding genes as barriers for CReasPy-Fusion by showing that their removal from the donor genome improves the cloning efficacy.